339 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Symbol Name Last Close Mkt Cap DailyStocks'
Rating
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Tuesday’s Close
ABT Abbott Laboratories $67.67 $118.71B Downtrend
Article Searches
Quest Diagnostics Grows on New Pacts Amid Reimbursement Issue http://www.zacks.com/stock/news/364204/quest-diagnostics-grows-on-new-pacts-amid-reimbursement-issue?cid=CS-ZC-FT-364204 Mar 25, 2019 - Quest Diagnostics' (DGX) partnership with UnitedHealthcare to operate as a preferred national laboratory seems strategic for the latter's customers.
6 Excellent Dividend Growth Stocks to Buy Now http://www.zacks.com/stock/news/364113/6-excellent-dividend-growth-stocks-to-buy-now?cid=CS-ZC-FT-364113 Mar 25, 2019 - The return of volatility with the escalation of global growth concerns and the risk of recession in the United States raises the appeal for dividend growth stocks.
Varian (VAR) Scales New 52-Week High on Solid Prospects http://www.zacks.com/stock/news/363525/varian-var-scales-new-52-week-high-on-solid-prospects?cid=CS-ZC-FT-363525 Mar 22, 2019 - The key growth driving factor for Varian (VAR) in the past year has been increasing net sales from major business segments.
Here's Why DexCom Shares Are Dropping Today https://www.fool.com/investing/2019/03/22/heres-why-dexcom-is-dropping-by-double-digits-toda.aspx?source=iedfolrf0000001 Mar 22, 2019 - The stock falls hard after a short-seller takes aim at the company.
Baxter (BAX) Soars to 52-Week High, Time to Cash Out? http://www.zacks.com/stock/news/363132/baxter-bax-soars-to-52-week-high-time-to-cash-out?cid=CS-ZC-FT-363132 Mar 22, 2019 - Baxter (BAX) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Abbott's (ABT) HeartMate 3 Pump Study Shows Favorable Results http://www.zacks.com/stock/news/362778/abbotts-abt-heartmate-3-pump-study-shows-favorable-results?cid=CS-ZC-FT-362778 Mar 21, 2019 - The use of Abbott's (ABT) HeartMate 3 pump can efficiently prolong life -term and improve the quality of life for advanced heart failure patients.
Edwards Lifesciences Presents Positive Partner 3 Trial Data http://www.zacks.com/stock/news/362780/edwards-lifesciences-presents-positive-partner-3-trial-data?cid=CS-ZC-FT-362780 Mar 21, 2019 - Edwards Lifesciences (EW) expects SAPIEN 3 to gain FDA approval for the low-risk indication in late-2019.
Abbott Laboratories (ABT) Chairman and CEO Miles D White Sold $6 million of Shares http://www.gurufocus.com/news/835562/abbott-laboratories-abt-chairman-and-ceo-miles-d-white-sold-6-million-of-shares Mar 20, 2019 - Abbott Laboratories (ABT) Chairman and CEO Miles D White Sold $6 million of Shares, Stocks: ABT, release date:Mar 20, 2019
Abbott (ABT) Gains Ground on Solid EPD and Diabetes Arms http://www.zacks.com/stock/news/362248/abbott-abt-gains-ground-on-solid-epd-and-diabetes-arms?cid=CS-ZC-FT-362248 Mar 20, 2019 - Abbott's (ABT) EPD business operates in emerging geographies like India, Russia, China and Latin America.
What Makes Abbott (ABT) a New Buy Stock http://www.zacks.com/stock/news/361472/what-makes-abbott-abt-a-new-buy-stock?cid=CS-ZC-FT-361472 Mar 19, 2019 - Abbott (ABT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Pages: 123456789...34

<<<Page 4>